Key facts
- Suma Krishnan, Krystal Biotech R&D president, sold $7.7 million in stock.
- The sale occurred on Tuesday.
- 150,000 shares were sold at an average price of $51.33 per share.
Suma Krishnan, the president of Research and Development at Krystal Biotech, sold $7.7 million worth of the company's stock on Tuesday. The transaction involved the sale of 150,000 shares at an average price of $51.33 per share. This represents a significant divestment by a key executive.